ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,417,835, issued on Sept. 16, was assigned to Verily Life Sciences LLC (Dallas).

"Imputation of blood glucose monitoring data" was invented by Joshua Burkart (Boston) and Nathan Dickerson Beach (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Introduced here are diabetes management platforms able to impute blood glucose level values for a subject whose glycemic health state is being monitored. These imputed values can be used to estimate the glycemic health state of the subject at a given point in time, identify appropriate recommendations for improving the glycemic health state, etc. More specifically, a diabetes management platform ca...